Friday, April 17, 2026
13.8 C
Los Angeles

AUSTRAC opens enrolment for new professions in next step for AML reforms

AUSTRAC is implementing the next phase of...

Revision of “Guidelines for Anti-Money Laundering and Combating the Financing of Terrorism”

The FSA revised "Guidelines for Anti-Money Laundering...

Sanctions Notice – ISIL (Da’esh) and Al-Qaida (UN Resolution 1267)

Please be advised that the Security Council...

Press Conference by KATAYAMA Satsuki, Minister of State for Financial Services

OpinionPress Conference by KATAYAMA Satsuki, Minister of State for Financial Services

Q.

I would like to ask about SANAE TOKEN. Yesterday, the company posted on social media that it would respond sincerely to the FSA’s investigation, but insisted that it was not in violation of the Payment Services Act. Has the FSA already started an investigation on this matter or conducted prior hearings? What progress has been made? I would also like to know if there have been any specific complaints from users. Lastly, I would like to ask you about your thoughts on the current situation, as it seems that there are other crypto-assets in addition to SANAE TOKEN that use the names of celebrities without permission.

A.

As this is an individual case, we cannot say what the situation includes all other cases. Generally speaking, the most important point is to protect users, so if there is a problem, we will certainly try to understand the actual situation. However, understanding the actual situation is not an investigation, so we will take appropriate measures with that in mind. I just heard from the secretary that NoBorder has issued a statement on its official X account announcing that it will cease this project, so I expect it to cease. In short, there was a statement on X that they had decided to cease this project, which I have now received.

Story from www.fsa.go.jp

Disclaimer: The views expressed in this article are independent views solely of the author(s) expressed in their private capacity.

Check out our other content

Ad


Check out other tags:

Most Popular Articles